A pilot study to determine the impact on dyslipidemia of the addition of tenofovir to stable background antiretroviral therapy in HIV-infected subjects

Trial Profile

A pilot study to determine the impact on dyslipidemia of the addition of tenofovir to stable background antiretroviral therapy in HIV-infected subjects

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Oct 2012

At a glance

  • Drugs Tenofovir disoproxil fumarate (Primary)
  • Indications HIV infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 07 Jun 2010 Planned end date (1 Jul 2007) added as reported by ClinicalTrials.gov record.
    • 07 Jun 2010 Actual initiation date (May 2005) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top